# Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma

> **NCT06199752** · PHASE4 · COMPLETED · sponsor: **Theodor Bilharz Research Institute** · enrollment: 90 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** probiotic agent 25 Billion CFU (Nowfoods, USA) , ). Inulin capsules 1000mg Herbamama USA

## Key facts

- **NCT ID:** NCT06199752
- **Lead sponsor:** Theodor Bilharz Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-12
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-09-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06199752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06199752, "Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06199752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*